The Company (Details) (USD $)	3 Months Ended		5 Months Ended	9 Months Ended							9 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2014 Segment	Sep. 30, 2013	Dec. 31, 2013	Sep. 30, 2014 Senior-Secured Credit Facilities [Member]	May 12, 2014 Senior-Secured Credit Facilities [Member]	Sep. 30, 2014 Revolving Credit Facility [Member]	May 12, 2014 Revolving Credit Facility [Member]	Sep. 30, 2014 Term Loan [Member]	May 12, 2014 Term Loan [Member]	Sep. 30, 2014 Minimum [Member]	Sep. 30, 2014 Minimum [Member] Senior-Secured Credit Facilities [Member] Eurodollar [Member]	Sep. 30, 2014 Maximum [Member]	Sep. 30, 2014 Maximum [Member] Senior-Secured Credit Facilities [Member] Eurodollar [Member]	Sep. 30, 2014 Forbearance Agreement [Member]	Sep. 30, 2014 Forbearance Agreement [Member] CB Floating Rate [Member]	Sep. 30, 2014 PhotoMedex, Inc. [Member]	Sep. 30, 2014 Radiancy, Inc. [Member]	Sep. 30, 2014 PhotoMedex Korea Ltd [Member]	Sep. 30, 2014 LCA Vision Inc [Member]
Business Acquisition [Line Items]
Maximum borrowing capacity							$ 85,000,000	$ 85,000,000	$ 10,000,000	$ 10,000,000	$ 75,000,000	$ 75,000,000
Term loan period											4 years
Effective interest rate (in hundredths)														3.25%		4.50%		4.00%
Possible increase in interest (in hundredths)																	2.00%
Effective date of merger																						May 12, 2014
Prepayments on term loan																	938,000
Percentage of exceeded cash on hand to be paid against revolving loans (in hundredths)																	0.75
Minimum amount of cash specified against payment of revolving loans																	18,000,000
Maximum capital expenditures on medical devices				575,000													575,000
Revolving loans payable	1,500,000		1,500,000	1,500,000													1,500,000
Lenders fee				196,000													196,000
Securities pledged as collateral (in shares)																				64,896	13,000
Percentage of ownership on reverse merger (in hundredths)																			20.00%	80.00%
Number of operating units				4
Percentage of shares acquired by wholly-owned subsidiary (in hundredths)																						100.00%
Revenue Recognition [Abstract]
Number of distribution channels				2
Period of sales deferred				14 days
Patient Receivables and Allowance for Doubtful Accounts [Abstract]
Minimum collection period of patient receivables				12 months
Maximum collection period of patient receivables				36 months
Bad debt expense, on patient receivables			244,000	133,000
Percentage of bad debt expenses on patient receivables (in hundredths)				1.00%
Finance and interest charges on patient receivables		205,000		318,000
Insurance Reserves [Abstract]
Insurance reserves	6,094,000		6,094,000	6,094,000
Derivatives [Abstract]
Balance of derivative instruments	632,000		632,000	632,000
Amount recognized as financing income	449,000			266,000
Notional amounts of foreign currency derivatives	17,807,000		17,807,000	17,807,000
Warranty on Product Sales [Line Items]
Period of warranty on product sales													1 year		2 years
Extended period of warranty on domestic sale of laser equipment													3 years		4 years
Activity in warranty accrual [Roll Forward]
Accrual at beginning of year				1,151,000	1,440,000
Additions charged to warranty expense				545,000	1,123,000
Expiring warranties				(209,000)	(344,000)
Claims satisfied				(667,000)	(1,077,000)
Total	820,000	1,142,000	820,000	820,000	1,142,000
Less: current portion	(755,000)	(1,071,000)	(755,000)	(755,000)	(1,071,000)	(1,094,000)
Accrued long-term warranty	$ 65,000	$ 71,000	$ 65,000	$ 65,000	$ 71,000
Weighted-average number of common and common equivalent shares outstanding [Abstract]
Basic number of common shares outstanding (in shares)	18,724,419	19,982,967		18,722,459	20,518,493
Dilutive effect of stock options and warrants (in shares)	0	458,295		0	458,295
Diluted number of common and common stock equivalent shares outstanding (in shares)	18,724,419	20,441,262		18,722,459	20,976,788
Common stock options and warrants excluded from computation of diluted earnings per share (in shares)	2,623,682	2,101,873		2,623,682	2,101,873